Paulus Kirchhof: Anticoagulation in Patients with a Single CHADS-VA Risk Factor
Paulus Kirchhof, Professor of Cardiovascular Medicine at the University of Birmingham, Professor of Medicine (Cardiology) and Director of the Department of Cardiology at the University Medical Center Hamburg-Eppendorf, shared a post on LinkedIn about his recent article, published in NEJM, adding:
“Anticoagulation in patients with a single CHADS-VA risk factor.
SINGLE-AF is an important trial that will inform clinical decisions.
The full paper is now available at the NEJM.
Many congratulations to all who realised SINGLE AF!
You can read my thoughts on SINGLE AF and on the use of anticoagulants in patients with atrial fibrillation and a single CHADS-VA risk factor here.
What is your take on anticoagulation in patients with atrial fibrillation and a single CHADS-VA risk factor?”
Title: Anticoagulation for Atrial Fibrillation with a Single Risk Factor for Stroke
Author: Paulus Kirchhof
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 18, 2026, 17:11Owen McCarty: Understanding Prekallikrein and Its Role in Inflammation and Thrombosis
-
Oct 18, 2026, 17:04Emna Gouider Belhadjali: Don’t Miss GPAS 2026 on Bleeding Disorders
-
Oct 18, 2026, 16:53Mehran Ghasemzadeh: Microparticle-Associated Mitochondrial DNA in Stored Platelet Products
-
Oct 18, 2026, 16:38Edward Lee Carter: A 15-Minute Blood Test for Brain Hemorrhage?
-
Oct 18, 2026, 16:29Patrick Taylor: Oral vs Transdermal Estrogen and Cardiovascular Risk in Menopausal Women
-
Oct 18, 2026, 16:19Artangela Henry: A Meaningful Week at the SCDAA National Convention
-
Oct 18, 2026, 16:04Emília Araújo։ New Insights Into the Genetics of Hemophilia B Leyden
-
Oct 18, 2026, 15:43André Marcel Harris: Award-Winning Research on Texas Sickle Cell Data Collection
-
Oct 18, 2026, 15:21Eleonora Gambineri: First Results of the IEI-Haem Consortium at ESID 2026